Artificial intelligence is driving a new phase in vaccine development, with researchers at the University of Cambridge creating a vaccine designed to protect against multiple coronaviruses. The AI-designed vaccine has already undergone initial human testing, marking the first instance where an antigen, the core component of a vaccine, has been entirely created by artificial intelligence and administered to volunteers. Unlike traditional vaccines that target a specific virus strain, the new appro